Remedy Plan Therapeutics Funding: $55M Raised, Seed
Remedy Plan Therapeutics is a Biotech company based in Rockville, MD. It has raised $55M in total funding. Latest round: Seed.
Remedy Plan Therapeutics funding overview
Remedy Plan Therapeutics is a Biotech company based in Rockville, MD. Remedy Plan Therapeutics has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed. Investors on record include Schooner Capital, Alexandria Venture Investments. 2 distinct backers are named across the disclosed rounds.
Remedy Plan Therapeutics at a glance
Total raised
$55M
Latest round
Seed
Industry
Biotech
Headquarters
Rockville, MD
Notable investors
Schooner Capital, Alexandria Venture Investments
Frequently asked about Remedy Plan Therapeutics funding
How much has Remedy Plan Therapeutics raised?
Remedy Plan Therapeutics has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Remedy Plan Therapeutics?
Schooner Capital, Alexandria Venture Investments are named among the investors backing Remedy Plan Therapeutics.
What was the latest Remedy Plan Therapeutics funding round?
The most recent disclosed round is a Seed.
Where is Remedy Plan Therapeutics based?
Remedy Plan Therapeutics is based in Rockville, MD.
What sector does Remedy Plan Therapeutics operate in?
Remedy Plan Therapeutics is tracked under Biotech from Rockville, MD, with $55M in disclosed funding.
Remedy Plan Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Rockville below to benchmark round size and investor mix.
